NextCure Inc expected to post a loss of 34 cents a share - Earnings Preview

NextCure

29/10/2024 11:18

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show no
change in
quarterly revenue when it reports  results on October 31
(estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for NextCure Inc is for a
loss
of 34 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for NextCure
Inc is
$4.00​, above​ its last closing price of $1.36. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.38       -0.38                        -46
 Jan. 1 0001   -0.46       -0.46                        -32.5
 Dec. 31 2023  -0.48       -0.54                        4​
 Sep. 30 2023  -0.66       -0.66                        22.4
 ​​Jan.        -0.59       -0.59      -0.64     Missed  -8.5
 1 0001                                                 
 Jan. 1 0001   -0.62       -0.62      -0.58     Beat    6.5​
 Jan. 1 0001   -0.65       -0.66      -0.62     Beat    5.5
 Sep. 30 2022  -0.62       -0.63      -0.68     Missed  -8.7
 This summary was machine generated October 29 at 11:17 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)